Editorial: Unmet therapeutic needs

Schizophrenia Bulletin

Volumn 31, Issue 4, 2005, Pages 793-794

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

CLINICAL RESEARCH; COGNITION; CONFERENCE PAPER; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; MENTAL HEALTH SERVICE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SYMPTOM; TREATMENT OUTCOME; CLINICAL TRIAL; COGNITIVE THERAPY; EDITORIAL; HUMAN; NEEDS ASSESSMENT; PSYCHOLOGY;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; COGNITIVE THERAPY; HUMANS; NEEDS ASSESSMENT; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 26444434436     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbi065     Document Type: Conference Paper

References (6)

1. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a metaanalysis of the outcome literature Am J Psychiat 1994;151(10):1409-1416.
2. Schizophrenia Bull 1998;24:1.
3. Schizophr Res 2004;72:1.
4. Carpenter WT. Clinical constructs and therapeutic discovery Schizophr Res 2004;72:69-73.
5. Scolnick E. Program to improve cognitive functioning in patients with schizophrenia: reflections Schizophr Res 2004;72:75-77.
6. Geyer MA, Tamminga CA. Measurement and Treatment Research to Improve Cognition in Schizophrenia: neuropharmacological aspects Psychopharmacology 2004;174:1-2.